Orienté Résultats, Pragmatique, Fiable
Brigitte Directeur Marketing - Ventes Pharma
Contacter Brigitte
Disponibilité : Dispo : Maintenant
Disponible en part-time: Oui

Profil mis à jour le : 13/05/2020

Mobile en france

1430 € HT par jour
 Ajouter aux favoris Publier un avis
1430 € HT/j
Disponibilité : Dispo : Maintenant
Mobile en france

Note Globale    

Brigitte

60 ans

Paris

Brigitte
Directeur Marketing - Ventes Pharma

Expériences professionnelles

 

Société de Conseil et de Management de Transition

CONSULTING ACTIVITIES

Jan 2018 - Mai 2020

  • Marketing - Sales - Patients program
  • Recruitment - Assessment
  • Mindfulness program for CEO, managers, patients, health professionals


FERRING PHARMACEUTICALS

BUSINESS UNIT MANAGER GYNEACOLOGY (Infertility-Obstetrics)

Jan 2012 - Jan 2018

Turnover: 50 M€ - 28 headcounts (43% of Total TO Ferring). 1st subsidiary in Europe

Member of Operating Committee

Outcomes:

  • Successful launch of the main product Menopur (25 M€) in 2015: TO Growth =+22%, Market share gain = +5 points
  • Achieved on record of Tractocile sales (11 M€ in 2015) against atosiban generics
  • Participated in market access and institutional relationships (price, reimbursement, HEOR)
  • Managed 3 Obstetrics and “IVF” boards (Oncofertility with Pr M.Grynberg, A.Toledano, Metabolic disease)

THERABEL

EUROPEAN BRAND MANAGER & HOSPITAL MARKETING MANAGER (Oncology Supportive Care)

Jan 2010 - Jan 2012

Outcomes:

  • Successful launch of hospital. Strong synergy with leaders & sales to reach Supportive Care positioning.
  • Managed an Oncologists board
  • Set up Medical Education Program strongly recognized by KOL and physicians

BEIERSDORF - EUCERIN

DETAILING MARKETING & SALES DIRECTOR

Jan 2007 - Jan 2010

DERMATOLOGIC DIVISION

Turnover 20 M€ - 21 headcounts

Member of Eucerin Operating Committee

Outcomes:

  • Launch of the Atopy range and the Anti-Age range (Hyaluron Filler, Dermo Densifyer).
  • Managed 2 Dermatology Boards : ATOPY & AESTHETIC

3M PHARMA

MARKETING MANAGER - CARDIOLOGY, PNEUMOLOGY, DERMATOLOGY, IMMUNOLOGY

Jan 2003 - Jan 2007

Turnover 90 M€ - 10 headcounts 1st subsidiary in Europe

Member of 3M Pharmaceuticals Operating Committee

Outcomes:

  • Main challenges: respiratory business sold, action plan to protect our market share of Flecaïne against generic penetration (60% of switch with the CR form), launch of a new therapeutic class, team building and motivation.
  • Portfolio management with partnership: Lamisil (Novartis), Tegaderm (3M), Dermgel (Valeant).
  • Managed 2 boards: CARDIOLOGY & DERMATOLOGY (Onco dermatology with ALDARA)

Formation

 

2019     Sup de Co & Cap Gemini; MOOC "Santé Publique - Consultant & Digital Strategy

2018     University degree; Université des Patients, Paris Sorbonne - "Démocratie en santé" Patient centric approach

2018     Digital Marketing for Pharmaceutical Industry

2005     Green Belt training - Six Sigma - Process and efficiency

1991     Institut Supérieur de Gestion, Paris (ISG); Ho Chi Minh Ville, Vietnam; Saatchi & Saatchi Medical - Master in Marketing and Communication in Pharmaceuticals

1985     Châtenay-Malabry University (Paris XI) - PhD in Pharmacy, Industry option

Langues

 

anglais : Bon niveau

Chargement...